EYLEA (Regeneron Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the EYLEA drug offered from Regeneron Pharmaceuticals, Inc.. This Vascular Endothelial Growth Factor Inhibitor [EPC],Vascular Endothelial Growth Factor Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Regeneron Pharmaceuticals, Inc. |
| NON-PROPRIETARY NAME: | aflibercept |
| SUBSTANCE NAME: | AFLIBERCEPT |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Vascular Endothelial Growth Factor Inhibitor [EPC],Vascular Endothelial Growth Factor Inhibitors [MoA] |
| ROUTE: | INTRAVITREAL |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2011-11-21 |
| END MARKETING DATE: | 0000-00-00 |
EYLEA HUMAN PRESCRIPTION DRUG Details:
| Item Description | EYLEA from Regeneron Pharmaceuticals, Inc. |
| LABELER NAME: | Regeneron Pharmaceuticals, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 40(mg/mL) |
| START MARKETING DATE: | 2011-11-21 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 61755-005_e24a1294-2b12-4bc6-b527-51e355e9d692 |
| PRODUCT NDC: | 61755-005 |
| APPLICATION NUMBER: | BLA125387 |
Other AFLIBERCEPT Pharmaceutical Manufacturers / Labelers:
